Bed Bath & Beyond ( BBBY ) is being sized up by investors and analysts after completing its acquisition of The Brand House Collective on April 2. The company also announced a separate $150M deal to acquire The Container Store, including Elfa and Closet Works, to expand its home-organization and retail footprint. Jefferies analyst Jonathan Matuszewski said the firm was encouraged by progress toward...
Bed Bath & Beyond ( BBBY ) is being sized up by investors and analysts after completing its acquisition of The Brand House Collective on April 2. The company also announced a separate $150M deal to acquire The Container Store, including Elfa and Closet Works, to expand its home-organization and retail footprint. Jefferies analyst Jonathan Matuszewski said the firm was encouraged by progress toward advancing Pillars 2 & 3 of Bed Bath & Beyond's "Everything Home Ecosystem" plan. He noted that while the all-stock structure suggests near-term dilution, the outcome was well telegraphed. Looking ahead, Matuszewski thinks another key consideration for investors will be the number of acquisitions being integrated simultaneously, which elevates execution and integration risk. Positives from the acquisition seen include increased exposure to the upper-middle-income consumer through The Container Store chain, entry into a high-margin custom closet business, and expanded home service offerings. Negatives could be that The Container Store’s cash profile may present a drag and the share dilution from the all-stock transaction. Wedbush Securities analyst Michael Piccolo said that in the near term, there is likely stock upside. However, he warned shares will likely remain measured pending "execution proof points" after the anticipated July closing date, and investors will be closely watching whether management can deliver on what the firm sees as a complex, simultaneous multi-brand integration amid an uncertain macroeconomic consumer spending environment. Shares of Bed Bath & Beyond ( BBBY ) were down 3.1% in premarket trading to $4.52 after recouping most of its post-deal announcement decline. The 52-week high for BBBY is $12.65. Short interest stands at 12.8% of the total float. More on Bed Bath & Beyond The Reasons I Am A Seller Of Bed Bath & Beyond Bed Bath & Beyond: A Turnaround May Be In Play Bed Bath & Beyond, Inc. (BBBY) Q4 2025 Earnings Call Transcript Bed Bath & Beyond fi...
Marc Andreessen Calls AI Job-Loss Fears 'Fake', Expects Employment Gains It is not the first time that the venture capital guru has questioned some of the fundamentally dystopian scenarios being proposition in an AI world. In February, we noted that amid an armada of dystopian futurists, projecting linear thoughts into a future of 'AI uber alles', Marc Andreessen stands as a beacon of potential ut...
Marc Andreessen Calls AI Job-Loss Fears 'Fake', Expects Employment Gains It is not the first time that the venture capital guru has questioned some of the fundamentally dystopian scenarios being proposition in an AI world. In February, we noted that amid an armada of dystopian futurists, projecting linear thoughts into a future of 'AI uber alles', Marc Andreessen stands as a beacon of potential utopian light, seeing a future that looks very different and very positive for young and old alike. In a brief few minutes, the co-founder of Netscape and VC firm Andreessen Horowitz (a16z) believes instead that we are living through a unique (and most incredible) time in history with the rise of AI coming right as human civilization needs it... "we're going to have AI and robots precisely when we actually need them [with populations shrinking] to keep the economy from actually shrinking." Simply put, Andreessen says that fears of AI-driven mass job loss are overly simplistic. After decades of unusually slow technological change and low job churn, AI could restore historical productivity levels (exemplified by the period from 1870-1930), sparking opportunity, innovation, and net job growth rather than displacement. Declining populations and reduced immigration will make human labor increasingly valuable. AI's timing is "miraculous", Andreessen exclaims, preventing economic shrinkage from depopulation. In even radical scenarios, explosive productivity leads to output gluts, collapsing prices, and massive real-wealth gains - equivalent to "giant raises" for everyone - while making safety-nets more affordable. Whether incremental or transformative, Andreessen sees the outcome as fundamentally positive economic news. Of course, he does have a lot of skin in this game... Building on that, CoinTelegraph's Christina Comben reports that Andreessen said artificial intelligence will spark a “massive jobs boom,” dismissing fears of widespread job losses as “all fake” in a Sunday post on...
Morsa Images/DigitalVision via Getty Images UNH Is Finally Moving When UnitedHealth Group Incorporated ( UNH ) heavily sold off in mid-May 2025 on potential DOJ probes and guidance cuts, I initiated my bullish coverage on it, arguing that the sell-off was overblown for the largest publicly traded managed care company in the United States. Since then, the stock hasn't moved much - it recovered by a...
Morsa Images/DigitalVision via Getty Images UNH Is Finally Moving When UnitedHealth Group Incorporated ( UNH ) heavily sold off in mid-May 2025 on potential DOJ probes and guidance cuts, I initiated my bullish coverage on it, arguing that the sell-off was overblown for the largest publicly traded managed care company in the United States. Since then, the stock hasn't moved much - it recovered by about 15% after the initial meltdown but then went into a prolonged consolidation within the new sideways range of 240-370/share. Seeking Alpha, my coverage of UNH Multiple times throughout the past year, I called for an eventual rise and repricing of UNH once the updated management team's efforts start to bear fruit, and now it seems we finally have major signs of that happening. The stock is trending right now before the market's opening (+7.69%) as the Centers for Medicare & Medicaid Services announced that the average Medicare Advantage payments will be boosted by 2.48% in 2027. Seeking Alpha News I believe the repricing that's currently taking place is fully justified, and it should keep going throughout calendar year 2026 as the internal fixes at UNH start to impact its finances as well. I still believe that for the position that UNH has on its addressable market, the stock's valuation is too discounted, even considering all the threats/fears. Rating UNH a "Buy" on this news seems to be fair, in my opinion, given the existing upside potential. Why Do I Think So? The whole business model of UNH and its peers is too reliant on MCR (Medical Care Ratio), and it's low-margin in nature, so when we saw FY2025 revenues of $447.6 billion (+12% YoY), the firm's adjusted MCR of 88.9%, which was a major 340 bps deterioration from 2024, led to a margin compression that didn't help UNH's price action momentum at all. Data by YCharts The guidance was ugly as well - the management projected a YoY revenue decline of ~2% in FY2026 (~$440 billion at the midpoint) - with the CMS (Centers ...
Indonesia’s central bank is continuing to intervene in the markets with stability its “top priority” following the currency’s three-day slide to multiple record lows against the dollar. “BI will optimize the use of all available monetary policy instruments and measures to maintain exchange rate stability,” Senior Deputy Governor Destry Damayanti said in a statement on Tuesday. The central bank “wi...
Indonesia’s central bank is continuing to intervene in the markets with stability its “top priority” following the currency’s three-day slide to multiple record lows against the dollar. “BI will optimize the use of all available monetary policy instruments and measures to maintain exchange rate stability,” Senior Deputy Governor Destry Damayanti said in a statement on Tuesday. The central bank “will consistently and measurably maintain a presence” in the spot, domestic non-deliverable forward and offshore NDF markets, she said. The rupiah has declined 0.6% against the greenback this month to surpass the key 17,000 level and the lows seen during the Asian Financial Crisis. It is among the worst in Asia as most regional currencies gained this month. The prolonged Iran war that catapulted oil prices fueling investors’ fiscal slippage concerns as increasing energy prices might add burdens on a state budget already pressured by accelerating spending for President Prabowo Subianto ’s flagship programs. The budget deficit widened further to 0.9% of gross domestic product as of March, with the fiscal authority estimating the gap could be close to the statutory cap of 3% of GDP by the end of this year. However, Indonesia’s position as a commodity exporter amid rising prices could be a boost to the economy, thereby offsetting the pressure on the exchange rate caused by the escalation of tensions from the conflict, Damayanti said. Governor Perry Warjiyo said during a March policy meeting that the central bank will continue to calibrate the optimal level of intervention to stabilize the rupiah during the war, adding that it will likely maintain the interest rate for the time being. BI also tightened foreign-exchange regulations to soften the impact of the Middle East tensions on inflation and the rupiah. The rupiah weakened 0.3% on Tuesday to 17,095 per dollar, the second-worst performer in the region after the Philippine peso. READ MORE: Indonesian Stocks, Rupiah Slump as Iran...
Golar LNG's 1 st Quarter 2026 results will be released before the market opens on Wednesday, May 20, 2026. In connection with this a webcast presentation will be held at 08:00am Eastern Time (1:00pm London Time) on Wednesday May 20, 2026. The presentation will be available to download from the Investor Relations section at www.golarlng.com
Golar LNG's 1 st Quarter 2026 results will be released before the market opens on Wednesday, May 20, 2026. In connection with this a webcast presentation will be held at 08:00am Eastern Time (1:00pm London Time) on Wednesday May 20, 2026. The presentation will be available to download from the Investor Relations section at www.golarlng.com
spawns Organogenesis ( ORGO ) shares jumped ~29% in the premarket on Tuesday after the regenerative medicine company said that a clinical trial for its wound care product PuraPlyAM was successful against diabetic foot ulcers (DFUs). The randomized controlled trial of 170 patients was designed to evaluate PuraPlyAM plus standard of care versus standard of care alone in the management of non-healing...
spawns Organogenesis ( ORGO ) shares jumped ~29% in the premarket on Tuesday after the regenerative medicine company said that a clinical trial for its wound care product PuraPlyAM was successful against diabetic foot ulcers (DFUs). The randomized controlled trial of 170 patients was designed to evaluate PuraPlyAM plus standard of care versus standard of care alone in the management of non-healing DFUs. Citing 12-week data, the biotech from Canton, Massachusetts, stated that the multi-center trial achieved the primary endpoint, as PuraPlyAM plus SOC caused a statistically significant wound closure compared to SOC alone. The company intends to publish the trial results in a peer-reviewed journal soon, a move that, according to Patrick Bilbo, its chief operating officer, could support PuraPly AM’s addition to coverage policies in the future. More on Organogenesis Holdings Organogenesis Facing Hard Times As It Adjusts To CMS Rule Changes Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript Organogenesis projects 25%-38% revenue decline in 2026 amid CMS-driven market disruption Organogenesis Holdings GAAP EPS of $0.24 beats by $0.03, revenue of $225.1M beats by $52.42M Seeking Alpha’s Quant Rating on Organogenesis Holdings
MarioGuti/iStock via Getty Images Listen below or on the go via Apple Podcasts and Spotify Insurance stocks jump on Medicare Advantage rate boost: Humana ( HUM ), UnitedHealth ( UNH ), lead gains. (00:14) SpaceX ( SPACE ) details IPO schedule ; retail demand expected to break records - report. (01:00) Amazon ( AMZN ) reduces its reliance on USPS as expected. (02:33) This is an abridged transcript....
MarioGuti/iStock via Getty Images Listen below or on the go via Apple Podcasts and Spotify Insurance stocks jump on Medicare Advantage rate boost: Humana ( HUM ), UnitedHealth ( UNH ), lead gains. (00:14) SpaceX ( SPACE ) details IPO schedule ; retail demand expected to break records - report. (01:00) Amazon ( AMZN ) reduces its reliance on USPS as expected. (02:33) This is an abridged transcript. The Trump administration will increase average Medicare Advantage payments by 2.48%, or more than $13 billion, in 2027, according to Centers for Medicare & Medicaid Services ( CMS ). Shares of major insurance companies are higher in premarket action , with Elevance Health ( ELV ) up 5.3%, UnitedHealth Group ( UNH ) up 6.9%, Humana ( HUM ) rising 10.5%, and CVS Health ( CVS ) up 6.3%. The Trump administration in January proposed a payment rate hike of 0.09%, which pummeled shares of insurers that run those plans. The payment rate determines how much insurers can charge for monthly premiums and plan benefits they offer and, ultimately, their profits. SpaceX ( SPACE ) provided details of its IPO during a Monday night meeting with its bankers. Reuters reported, citing sources familiar with the matter that SpaceX ( SPACE ) plans to kick off its IPO roadshow the week of June 8 , where company representatives and bankers will pitch to investors. SpaceX ( SPACE ) has scheduled a meeting with around 125 financial analysts from the 21 banks involved in the deal the day before. One of SpaceX’s ( SPACE ) lead underwriters told the group of 21 investment banks that the level of retail demand and the size of the retail allocation would be something they have “never seen before.” On June 11, SpaceX ( SPACE ) plans to host 1,500 retail investors at what the sources described as a major investor event. Alongside U.S. investors, retail investors from the UK, EU, Australia, Canada, Japan, and Korea will also have the opportunity to participate in the offering, the report added. The IPO prosp...